Agilent Technologies (A) vs Bio-Rad Laboratories (BIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Bio-Rad Laboratories (BIO) has outperformed Agilent Technologies (A) over the past year, gaining 24.1% versus a gain of 22.0%. Over five years, A leads with a +10.3% price change compared with -49.0% for BIO. Agilent Technologies is the larger company by market cap ($47.68 billion vs $9.84 billion), about 4.8 times the size.
On valuation, Agilent Technologies trades at a lower forward P/E (25.0x vs 37.1x for Bio-Rad Laboratories). Agilent Technologies pays a dividend yielding 0.60%, while Bio-Rad Laboratories does not currently pay one. Bio-Rad Laboratories converts more of its revenue into profit, with a net margin of 29.4% versus 18.8%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | A | BIO |
|---|---|---|
| Share price | $169.09 | $367.92 |
| Market cap | $47.68B | $9.84B |
| 1-day change | -0.14% | -0.25% |
| YTD return | +24.27% | +21.43% |
| 1-year return | +22.03% | +24.08% |
| 5-year return | +10.32% | -49.00% |
| P/E ratio (TTM) | 33.35 | 46.75 |
| Forward P/E | 25.02 | 37.10 |
| EPS (TTM) | $5.07 | $7.87 |
| Dividend yield | 0.60% | 0.00% |
| Annual dividend | $1.01 | $0.00 |
| Revenue (latest FY) | $6.95B | $2.58B |
| Revenue growth (YoY) | +6.73% | +0.65% |
| Net income (latest FY) | $1.30B | $759.90M |
| Gross margin | 52.43% | 51.87% |
| Operating margin | 21.29% | 1.83% |
| Net margin | 18.75% | 29.42% |
| 52-week high | $177.05 | $396.23 |
| 52-week low | $108.35 | $236.73 |
| Distance from 52-week high | -4.50% | -7.14% |
| Analyst consensus | buy | hold |
| Avg. price target upside | +4.38% | -10.76% |
| Average volume | 2.26M | 277.32K |
| Shares outstanding | 281.97M | 21.68M |
| Employees | 18,200 | 7,450 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Agilent Technologies is about 4.8 times larger than Bio-Rad Laboratories by market value ($47.68B vs $9.84B).
- Bio-Rad Laboratories trades at a higher earnings multiple (46.7x vs 33.4x trailing P/E).
- Bio-Rad Laboratories is more profitable, keeping 29.4 cents of every revenue dollar as net income versus 18.8 cents for Agilent Technologies.
- Agilent Technologies grew revenue faster in its latest fiscal year (+6.73% vs +0.65%).
About Agilent Technologies
A stock →Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
Industrials · Biotechnology: Laboratory Analytical Instruments · 18,200 employees
About Bio-Rad Laboratories
BIO stock →Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally.
Industrials · Biotechnology: Laboratory Analytical Instruments · 7,450 employees
A vs BIO FAQ
Which is bigger, Agilent Technologies or Bio-Rad Laboratories?
Agilent Technologies (A) is larger, with a market capitalization of $47.68B compared with $9.84B for Bio-Rad Laboratories (BIO).
Which stock has performed better over the past year, A or BIO?
BIO returned +24.08% over the past 12 months, compared with +22.03% for A (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, A or BIO?
A has the lower trailing P/E at 33.4, versus 46.7 for BIO. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Agilent Technologies or Bio-Rad Laboratories?
Agilent Technologies pays a dividend yielding 0.60%, while Bio-Rad Laboratories does not currently pay a regular dividend.
Are Agilent Technologies and Bio-Rad Laboratories in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.